A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety-Reference-Cited by-同舟云学术

A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety

Published:2019-06-20 Issue:8 Volume:28 Page:1077-1085
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Forshee Richard A.¹,Hu Mao²^ORCID,Arya Deepa¹,Perez‐Vilar Silvia¹,Anderson Steven A.¹,Lo An‐Chi²,Swarr Madeline²,Wernecke Michael²,MaCurdy Tom²³,Chu Steve⁴,Kelman Jeffrey⁴

Affiliation:

1. Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and ResearchUS Food and Drug Administration Silver Spring Maryland USA

2. Acumen LLC Burlingame California USA

3. Department of EconomicsStanford University Stanford California USA

4. Center for MedicareCenters for Medicare and Medicaid Services Baltimore Maryland USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4807

Reference30 articles.

1. Surveillance for Guillain–Barré Syndrome After Influenza Vaccination Among the Medicare Population, 2009–2010

2. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

3. Chart-Confirmed Guillain-Barre Syndrome After 2009 H1N1 Influenza Vaccination Among the Medicare Population, 2009-2010

4. Guillain-Barré Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe

5. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Seasonality-Adjusted Sequential Test for Vaccine Safety Surveillance;Biometrics;2023-01-16

2. Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018–2019 Season;The Journal of Infectious Diseases;2020-11-02